Markets:

Overview

News

Currencies

International

Treasuries

Teva Pharmaceutical Industries Limited Ordinary Shares (NY:TEVA)

41.52 +1.55 (+3.87%)

Delayed Quote Updated: 3:59 PM EDT, Oct 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries Limited Ordinary Shares

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

35 36 Next >

Key Takeaways From Teva Pharmaceutical Indus Analyst Ratings ↗

September 03, 2024

Via Benzinga

Organon Stock Sees Relative Strength Rating Rise To 91 ↗

August 27, 2024

On Tuesday, Organon[ stock hit an key technical milestone, seeing its Relative Strength Rating jump to 91, up from 88 the day before.

Via Investor's Business Daily

Teva to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

August 26, 2024

From Teva Pharmaceutical Industries Ltd

Via GlobeNewswire

Novo Nordisk's Ozempic Might Be Among 2027 Medicare Price Negotiation Targets ↗

August 23, 2024

Analysts expect Novo Nordisk's Ozempic and other major drugs to be included in 2027 Medicare price negotiations. Despite concerns, experts predict limited financial impact on companies like Pfizer,...

Via Benzinga

$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,400 Today ↗

August 21, 2024

Via Benzinga

Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings ↗

July 29, 2024

The unfolding week's market trajectory depends on earnings from bellwether tech stocks and what the Fed has to say following its July meeting.

Via Benzinga

Topics Economy

$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today ↗

July 19, 2024

Via Benzinga

Organon Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold ↗

August 20, 2024

On Tuesday, generic drug maker Organon stock had its Relative Strength (RS) Rating upgraded to 83, up from 78 a day earlier.

Via Investor's Business Daily

$100 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth This Much Today ↗

August 13, 2024

Via Benzinga

The 7 Best Under $20 Stocks to Buy in August 2024 ↗

August 07, 2024

Although cheap stocks are often cheap for a reason, it doesn't hold true for the best stocks under $20, which is where investors can profit.

Via InvestorPlace

Revolutionary Magnetic Therapy Could Speed Up Bipolar Treatment

August 06, 2024

New research suggests that powerful magnets could effectively treat bipolar disorder. This therapy, which is known as accelerated intermittent theta burst stimulation (iTBS), uses magnetic waves...

Via PressReach

What Are the Hottest Biotech Stocks Right Now? 3 Top Picks. ↗

August 02, 2024

Figuring out the hottest biotech stocks can be as simple as looking at the most traded stocks by volume in the last 24 hours.

Via InvestorPlace

Tech Stocks On Track For Best Session In 5 Months Ahead Of Fed Meeting; Small Caps Target Highest Close Since January 2022: What's Driving Markets Wednesday? ↗

July 31, 2024

Tech stocks soared to their best session in five months on Wednesday, ahead of the highly anticipated Federal Open Market Committee (FOMC) meeting.

Via Benzinga

Topics Economy

Match Group Posts Upbeat Sales, Joins Modine Manufacturing, Scotts Miracle-Gro, NVIDIA And Other Big Stocks Moving Higher On Wednesday ↗

July 31, 2024

Via Benzinga

Teva Pharmaceutical Industries (TEVA) Q2 2024 Earnings Call Transcript ↗

July 31, 2024

TEVA earnings call for the period ending June 30, 2024.

Via The Motley Fool

Topics Earnings

Teva Beats Q2 Estimates, Raises Annual Outlook On Strong Generic, Austedo Sales ↗

July 31, 2024

Teva Pharmaceutical reported Q2 2024 sales of $4.16 billion, surpassing the $4.06 billion consensus. Revenue rose 7% YoY, driven by growth in generic products and Austedo sales. Adjusted EPS was $0.61,...

Via Benzinga

Teva Pharma Flirts With Breakout As Generic Drugs Drive Beat-And-Raise ↗

July 31, 2024

The company now expects $16 billion to $16.4 billion in full-year sales.

Via Investor's Business Daily

Teva Announces Strong Growth in Second Quarter Revenues mainly driven by Generics Products in All Regions and AUSTEDO®; Raises 2024 Financial Guidance

July 31, 2024

From Teva Pharmaceutical Industries Ltd

Via GlobeNewswire

Wall Street Remains On Track For AMD-Led Rebound Ahead Of Fed Decision, Meta Earnings: Analyst Says 'The Bull Tends To Remain' Despite Near-Time Volatility ↗

July 31, 2024

Tech optimism is likely to abound on Wall Street as AI-levered stocks are feeding off the strength generated by Advanced Micro Devices, Inc.‘s (NASDAQ:AMD)

Via Benzinga

Topics Economy

10 Health Care Stocks Whale Activity In Today's Session ↗

July 30, 2024

Via Benzinga

Teva and Sanofi Announce Accelerated Timeline for Anti-TL1A Phase 2b Program in Patients with Inflammatory Bowel Disease

July 25, 2024

From Teva Pharmaceutical Industries Limited

Via Business Wire

Why Hims & Hers Heath Shares Are Surging Today ↗

July 22, 2024

Hims & Hers Health Inc. (NYSE: HIMS) shares are moving higher on Monday amidst the announcement of Kåre Schultz's appointment to the Board of Directors.

Via Benzinga

Teva's Migraine Treatment Found Effective For Children As Young As 6 ↗

July 18, 2024

Teva Pharmaceutical's Phase 3 SPACE study reveals Ajovy's significant efficacy in preventing episodic migraines in children aged 6-17. The trial's primary endpoint was met with safety data aligning...

Via Benzinga

Teva Announces First Phase 3 Evidence of Efficacy and Safety of an Anti-CGRP Monoclonal Antibody in Children in AJOVY® (fremanezumab) SPACE Trial for Prevention of Episodic Migraine

July 18, 2024

From Teva Pharmaceutical Industries Limited

Via Business Wire

Jim Cramer Says Don't Sell Match Group: 'You've Just Got A Very, Very Smart Investor In There' ↗

July 17, 2024

Jim Cramer doesn't favor Fortinet, but owns Palo Alto Networks for charity. Air Products not doing well due to better run company Linde.

Via Benzinga

3 No-Brainer Stocks to Buy With $200 Right Now ↗

July 17, 2024

A modest amount of money can go a long way on Wall Street when it's put to work in innovation-driven businesses.

Via The Motley Fool

Here's How Much $1000 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth Today ↗

July 16, 2024

Via Benzinga

Teva Pharmaceuticals Stock: Unlock Value in This Generic Drug Gem

July 10, 2024

Drug prices continue to rise, driving up healthcare costs. Pharmaceutical companies usually hike drug prices at the beginning of each year. In January 2024

Via MarketBeat

Teva to Host Conference Call to Discuss Second Quarter 2024 Financial Results at 8 a.m. ET on July 31, 2024

July 02, 2024

From Teva Pharmaceutical Industries Limited

Via Business Wire

FTC Crackdown on Teva Pharmaceuticals Over Inhaler Patent Abuse ↗

July 01, 2024

The FTC is investigating Teva Pharmaceuticals for alleged misuse of inhaler patents to block generic competition and maintain high prices in the U.S. while selling the same products for less overseas.

Via Benzinga

Topics Intellectual Property

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

35 36 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.